Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis.

Massimiliano Camilli, Marco Lombardi, Marco Giuseppe Del Buono, Juan Guido Chiabrando, Rocco Vergallo, Giampaolo Niccoli, Rocco Antonio Montone, Filippo Crea

Journal: European heart journal. Cardiovascular pharmacotherapy 2022;7(3):e21-e25

PMID: 33245110

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy.; Department of Interventional Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.; Health Science Statistics Applied Laboratory (LEACS), Pharmacology and Toxicology Department, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina.; Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli, 1-00168 Rome, Italy.; Division of Cardiology, University of Parma, Parma University Hospital, Parma, Italy.

DOI: 10.1093/ehjcvp/pvaa134

Link outs

Free resources

Medical:

https://medlineplus.gov/bloodthinners.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Anticoagulants, Fibrinolytic Agents, Humans, Thrombosis, Vitamin K